We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WHO Criticizes Manufacturers Over Pricey Hep C Drugs
WHO Criticizes Manufacturers Over Pricey Hep C Drugs
The World Health Organization lashed out at Johnson & Johnson and Gilead for selling oral hepatitis C drugs that are too expensive to be adopted in developing countries.